ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT03448042 updates: 1. completion date: 2026-11-30 → 2027-11-30 2. primary completion date: 2026-11-30 → 2027-11-30 3. enrollment: not set → 123 participants
Clinical trial NCT03448042 updates: 1. completion date: 2026-11-30 → 2027-11-30 2. primary completion date: 2026-11-30 → 2027-11-30 3. enrollment: not set → 123 participants
Clinical trial NCT07444320: enrollment: not set → 200 participants.
Clinical trial NCT07221474: enrollment: not set → 180 participants.
Clinical trial NCT05313555 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2025-09-01 → 2022-09-12 3. primary completion date: 2025-09-01 → 2022-09-12 4. enrollment: not set → 23 participants
Clinical trial NCT05419492: enrollment: not set → 47 participants.
Clinical trial NCT06735534: enrollment: not set → 376 participants.
Clinical trial NCT07604844: enrollment: not set → 120 participants.
Clinical trial NCT06131398 updates: 1. completion date: 2026-08-03 → 2026-07-21 2. primary completion date: 2026-05-24 → 2026-07-21 3. enrollment: not set → 77 participants
Clinical trial NCT07541534 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-10 → 2026-05-22 3. enrollment: not set → 41 participants
Clinical trial NCT05764954 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 12 participants